Advisory Services Network’s Opiant Pharmaceuticals OPNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-350
Closed -$3K – 3173
2020
Q4
$3K Buy
+350
New +$2.75K ﹤0.01% 2954
2020
Q2
– Sell
-4,000
Closed -$38K – 2946
2020
Q1
$38K Sell
4,000
-2,000
-33% -$23.9K ﹤0.01% 1523
2019
Q4
$86K Buy
+6,000
New +$87.5K ﹤0.01% 1228

Other funds holding OPNT

Advisory Services Network's OPNT Position: Q1 2021 in Review

Advisory Services Network sold out of Opiant Pharmaceuticals (OPNT) in Q1 2021, closing a stake of 350 shares — an estimated $3K sold.

Advisory Services Network first reported a position in OPNT in Q4 2019 and held it in 3 quarters. The position peaked at $86K in Q4 2019. 31 funds tracked by Wall St. Rank hold OPNT as of Q1 2021.

  • Advisory Services Network reported no remaining Opiant Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Advisory Services Network sold 350 Opiant Pharmaceuticals shares in Q1 2021, an estimated $3K.
  • Advisory Services Network first reported a position in Opiant Pharmaceuticals in Q4 2019 and held it in 3 quarters.
  • Advisory Services Network's Opiant Pharmaceuticals position peaked at $86K in Q4 2019.
  • 31 funds tracked by Wall St. Rank held Opiant Pharmaceuticals as of Q1 2021.

Based on Advisory Services Network's 13F filing for Q1 2021, filed 24 May 2021.